Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin

Hypertension

Volumn 28, Issue 5, 1996, Pages 758-764

  Davidge, Sandra T ^a,b   Signorella, Arthur P ^a   Hubel, Carl A ^a   Lykins, David L ^a   Roberts, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

endothelium; lipids; lipoproteins; nitric oxide; preeclampsia; pregnancy; prostaglandin

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CHARCOAL; LIPID; LIPOPROTEIN; NITRIC OXIDE; NITRITE; PROSTACYCLIN;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME IMMUNOASSAY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPERTENSION; HYPERURICEMIA; NONHUMAN; PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA;

EID: 0029957929     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.5.758     Document Type: Article

References (43)

1. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnick R, eds. Maternal-Fetal Medicine: Principles and Practice. Philadelphia, Pa: WB Saunders; 1984:703-752.
2. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of pre-eclampsia. Clin Perinatol. 1991;18:661-682.
3. Myatt L. Eicosanoid and blood pressure regulation. In: Sharp F, Symonds EM, eds. Hypertension in Pregnancy: Proceedings, 16th Study Group RCOG. New York, NY: Perinatology Press; 1987:167-182.
4. Bussolino F, Benedetto C, Massobrio M, Camussi G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet. 1980;2:702. Letter.
5. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of NO in the pathogenesis of preeclampsia. Am J Obstet Gynecol. 1994;171:944-948.
6. Curtis NE, Gude NM, King RG, Marriott PJ, Rook TJ, Brennecke SP. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Preg. 1995;14:339-349.
7. Brown MA, Tibben E, Zammit VC, Cario GM, Carlton MA. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Preg. 1995;14:319-326.
8. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol. 1996;174:1008-1013.
9. Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, Martinelli P. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991; 164:507-513.
10. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993;341:1447-1451.
11. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gvnecol. 1989;161:1200-1204.
12. Taylor RN, Musci TJ, Rodgers GM, Roberts JM. Prepartum preeclamptic sera stimulate platelet-derived growth factor mRNA and protein production by cultured human endothelial cells. Am J Reprod Immunol 1991;25:105-108.
13. Lorentzen B, Endresen MJ, Haug THE, Henriksen T. Sera from preeclamptic women increase the content of triglycerides and reduce the release of prostaglandin in cultured endothelial cells. Thromb Res. 1991;63:363-372.
14. Roberts JM, Edep ME, Goldfein A, Taylor RN. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro. Am J Reprod Immunol. 1992;27:101-108.
15. Branch DW, Dudley DJ, LaMarche S, Mitchell MD. Sera from preeclamptic patients contains factor(s) that stimulate prostacyclin production by human endothelial cells. Prostaglandins Leukot Essent Fatty Acids. 1992;45:191-195.
16. deGroot CJM, Davidge ST, Friedman SA, McLaughlin MK, Roberts JM, Taylor RN. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol. 1995;172:976-985.
17. Baker PN, Davidge ST, Roberts JM. Plasma from women with preeclampsia increased endothelial cell NO production. Hypertension. 1995;26:244-248.
18. Davidge ST, Baker PN, Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol. 1995;269:H1106-H1112.
19. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem. 1982;126:131-138.
20. 15N] nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
21. Chen RF. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem. 1967;242:173-181.
22. Havel RJ, Eder H, Bragdon J. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1995;34:1345-1353.
23. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968;9:693-700.
24. Peterson GL. A simplification of the protein assay method of Lowry, et al. which is more generally applicable. Anal Biochem. 1977;83: 346-356.
25. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978;19:65-76.
26. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979;133:165-170.
27. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol. 1992;167:440-447.
28. Chirico S, Smith C, Merchant C, Mitchinson MJ, Halliwell B. Lipid peroxidation in hyperlipidemic patients: a study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Biol Med. 1993; 19:51-57.
29. Pronai L, Hiramatsu K, Saigusa Y, Nakazawa H. Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes. Atherosclerosis. 1991;90:39-47.
30. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Current Opin Lipidol. 1994;5:339-349.
31. Witztum JL. Susceptibility of low-density lipoprotein to oxidative modification. Am J Med. 1993;94:347-349.
32. Griffin BA. Low-density lipoprotein heterogeneity. Baillieres Clin Endocrinol Metab. 1995;9:687-703.
33. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rodgers GM, McLaughlin MK. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol. 1989;161:1025-1034.
34. Walsh SC. Lipid peroxidation in pregnancy. Hypertens Preg. 1994; 13:1-25.
35. Ware Branch D, Mitchell MD, Miller E, Palinski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet. 1994;343:645-646.
36. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res. 1995; 76:958-962.
37. Weisser B, Locher R, Mengden T, Vetter W. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler Thromb. 1992;12:231-236.
38. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelial-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
39. Jacobs M, Plane F, Bruckdorfer KR. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in rabbit aorta. Br J Pharmacol. 1990;100:21-26.
40. Mehta JL, Bryant JL, Mehta P. Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Biochem Pharmacol. 1995;50:1181-1185.
41. Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem. 1980; 255:6253-6261.
42. Kobayashi K, Watanabe J, Umeda F, Taniguchi S, Masakado M, Yamauchi T, Nawata H. Enhancement of prostacyclin production in cultured bovine aortic endothelial cells by oxidized glycated low-density lipoprotein. Prostaglandins Leukot Essent Fatty Acids. 1995; 52:263-270.
43. Natarajan V. Oxidants and signal transduction in vascular endothelium. J Lab Clin Med. 1995;125:26-37.